TY - JOUR
T1 - Differential attenuation of some effects of haloperidol in rats given scopolamine
AU - Setler, Paulette
AU - Sarau, Henry
AU - McKenzie, Gerald
PY - 1976/9
Y1 - 1976/9
N2 - In a series of pharmacologica tests the ability of 0.6 mg/kg of the anticholinergic scopolamine to decrease the effectiveness of the neuroleptic haloperidol varied widely. Most severely attenuated was production of catalepsy followed in order of decreasing interference by inhibition of amphetamine-induced rotation, inhibition of amphetamine- or apomorphine-induced stereotyped behavior, inhibition of conditioned avoidance responding and lastly attenuation of the haloperidol-induced increase in striatal HVA. By use of such a relatively low dose of scopolamine the behavioral effects of haloperidol were dissociated from effects on dopamine turnover in the striatum. If behavioral tests in animals can be related to the clinical effects of neuroleptic drugs, those effects of haloperidol severely reduced by scopolamine may be related to extrapyramidal effects.
AB - In a series of pharmacologica tests the ability of 0.6 mg/kg of the anticholinergic scopolamine to decrease the effectiveness of the neuroleptic haloperidol varied widely. Most severely attenuated was production of catalepsy followed in order of decreasing interference by inhibition of amphetamine-induced rotation, inhibition of amphetamine- or apomorphine-induced stereotyped behavior, inhibition of conditioned avoidance responding and lastly attenuation of the haloperidol-induced increase in striatal HVA. By use of such a relatively low dose of scopolamine the behavioral effects of haloperidol were dissociated from effects on dopamine turnover in the striatum. If behavioral tests in animals can be related to the clinical effects of neuroleptic drugs, those effects of haloperidol severely reduced by scopolamine may be related to extrapyramidal effects.
UR - http://www.scopus.com/inward/record.url?scp=0017077479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017077479&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(76)90119-9
DO - 10.1016/0014-2999(76)90119-9
M3 - Article
C2 - 986946
AN - SCOPUS:0017077479
SN - 0014-2999
VL - 39
SP - 117
EP - 126
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -